US judge won't block Eli Lilly ads for weight-loss drugs, rules against Novo Nordisk - Reuters

More in Science

• STAT+: Roche gets a lung cancer win with its KRAS drug divarasib

  Roche's drug divarasib has demonstrated significant improvements in treating second-line advanced non-small cell lung cancer, outperforming older KRAS inhibitors from Amgen and Bristol Myers Squibb. This breakthrough is particularly noteworthy for Roche, which has been focusing on developing targeted therapies for lung cancer. The study, presented at the European Society for Medical Oncology (ESMO) meeting, shows promise for patients with KRAS G12C mutations.

  1 min read
• Haze in Singapore: Normal PM2.5 and good to moderate 24-hour PSI readings islandwide

  Despite a week of poor haze, Singapore's air quality improved significantly, with normal PM2.5 readings and good-to-moderate 24-hour PSI levels across the island. The National Environment Agency (NEA) noted that air quality was better after a week of poor haze, and showers and wet weather were expected to help keep smoke and hotspots down.

  2 min read
• Commentary: Singapore is doing more heritage studies – but does it have enough experts?

  Singapore is expanding its heritage studies, but it may lack the necessary expertise. The National Heritage Board acknowledges the need to build local expertise but has faced increasing urgency as archaeological work becomes part of development-related heritage studies. The problem does not end with the investigation, as conclusions can determine whether more investigation is needed, remains are retained, or development proceeds. A finding that a site has little or no significance is not inherently wrong, but it s…

  5 min read